UA75597C2 - A synthetic process for producing ecteinachidine compound - Google Patents

A synthetic process for producing ecteinachidine compound Download PDF

Info

Publication number
UA75597C2
UA75597C2 UA20021210093A UA20021210093A UA75597C2 UA 75597 C2 UA75597 C2 UA 75597C2 UA 20021210093 A UA20021210093 A UA 20021210093A UA 20021210093 A UA20021210093 A UA 20021210093A UA 75597 C2 UA75597 C2 UA 75597C2
Authority
UA
Ukraine
Prior art keywords
compound
solution
nmr
mmol
group
Prior art date
Application number
UA20021210093A
Other languages
English (en)
Ukrainian (uk)
Inventor
Maria Jesus Martin
Original Assignee
Pharma Mar Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/GB2000/001852 external-priority patent/WO2000069862A2/en
Application filed by Pharma Mar Sa filed Critical Pharma Mar Sa
Publication of UA75597C2 publication Critical patent/UA75597C2/uk

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/08—Bridged systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/18—Bridged systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/22—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed systems contains four or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/22—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains four or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D497/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having oxygen and sulfur atoms as the only ring hetero atoms
    • C07D497/22—Heterocyclic compounds containing in the condensed system at least one hetero ring having oxygen and sulfur atoms as the only ring hetero atoms in which the condensed system contains four or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D515/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen, oxygen, and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D515/22—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen, oxygen, and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains four or more hetero rings
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Saccharide Compounds (AREA)
  • Discharging, Photosensitive Material Shape In Electrophotography (AREA)
  • Instruments For Viewing The Inside Of Hollow Bodies (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Pyrane Compounds (AREA)
UA20021210093A 2000-05-15 2001-05-15 A synthetic process for producing ecteinachidine compound UA75597C2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
PCT/GB2000/001852 WO2000069862A2 (en) 1999-05-14 2000-05-15 Hemisynthetic method and intermediates thereof
PCT/GB2001/002120 WO2001087895A1 (en) 1999-05-14 2001-05-15 Synthetic process for the manufacture of an ecteinaschidin compound

Publications (1)

Publication Number Publication Date
UA75597C2 true UA75597C2 (en) 2006-05-15

Family

ID=34855248

Family Applications (1)

Application Number Title Priority Date Filing Date
UA20021210093A UA75597C2 (en) 2000-05-15 2001-05-15 A synthetic process for producing ecteinachidine compound

Country Status (16)

Country Link
EP (3) EP1287004B1 (pl)
KR (2) KR100830717B1 (pl)
AT (2) ATE368671T1 (pl)
AU (2) AU783563B2 (pl)
DE (3) DE60107241T2 (pl)
DK (3) DK1289999T3 (pl)
EA (2) EA006070B1 (pl)
ES (2) ES2290583T3 (pl)
GB (1) GB9918178D0 (pl)
HU (1) HU228789B1 (pl)
MX (1) MXPA02010701A (pl)
NZ (2) NZ521807A (pl)
PL (1) PL203745B1 (pl)
PT (3) PT1287004E (pl)
SI (2) SI1289999T1 (pl)
UA (1) UA75597C2 (pl)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101188691B1 (ko) 2004-10-29 2012-10-09 파르마 마르 에스.에이. 엑티나시딘 및 디사카라이드를 포함하는 제제
KR100676324B1 (ko) * 2005-03-15 2007-01-30 삼성전자주식회사 디스플레이장치
KR100676325B1 (ko) * 2005-03-15 2007-01-30 삼성전자주식회사 디스플레이장치
KR100712667B1 (ko) * 2006-04-11 2007-05-02 재단법인서울대학교산학협력재단 신규한 디아자 헤테로고리 유도체 및 그의 고체상 제조방법
AU2011257277B2 (en) * 2010-05-25 2016-02-25 Pharma Mar, S.A. Synthetic process for the manufacture of ecteinascidin compounds
US11332480B2 (en) 2017-04-27 2022-05-17 Pharma Mar, S.A. Antitumoral compounds
WO2020105068A1 (en) * 2018-11-24 2020-05-28 Natco Pharma Limited Process for the preparation of ecteinascidin derivative and its intermediate

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS59225189A (ja) 1983-06-03 1984-12-18 Shionogi & Co Ltd キノナミン誘導体およびその製造法
AU589282B2 (en) * 1986-06-09 1989-10-05 University Of Illinois Ecteinascidins 729, 743, 745, 759a, 759b and 770
US5721362A (en) * 1996-09-18 1998-02-24 President And Fellows Of Harvard College Process for producing ecteinascidin compounds
US6124292A (en) * 1998-09-30 2000-09-26 President And Fellows Of Harvard College Synthetic analogs of ecteinascidin-743

Also Published As

Publication number Publication date
DE60112286T2 (de) 2006-06-01
DE60112286D1 (de) 2005-09-01
KR100777464B1 (ko) 2007-11-27
DK1496060T3 (da) 2007-12-03
PT1496060E (pt) 2007-10-30
KR20030031481A (ko) 2003-04-21
KR100830717B1 (ko) 2008-05-20
ATE300547T1 (de) 2005-08-15
EA006369B1 (ru) 2005-12-29
EP1496060A1 (en) 2005-01-12
AU783563B2 (en) 2005-11-10
NZ532793A (en) 2004-10-29
EP1496060B1 (en) 2007-08-01
MXPA02010701A (es) 2003-05-14
HUP0300648A3 (en) 2006-05-29
PT1289999E (pt) 2005-03-31
DK1287004T3 (da) 2005-11-28
EA200201210A1 (ru) 2003-04-24
EP1287004B1 (en) 2005-07-27
DE60107241T2 (de) 2006-08-03
DE60129753D1 (de) 2007-09-13
AU5649301A (en) 2001-11-26
SI1496060T1 (sl) 2008-06-30
DE60107241D1 (de) 2004-12-23
ATE368671T1 (de) 2007-08-15
EA200201209A1 (ru) 2003-04-24
EA006070B1 (ru) 2005-08-25
ES2248319T3 (es) 2006-03-16
PL203745B1 (pl) 2009-11-30
DE60129753T2 (de) 2008-04-30
AU2001256496B2 (en) 2006-02-16
EP1289999B1 (en) 2004-11-17
DK1289999T3 (da) 2005-03-14
ES2290583T3 (es) 2008-02-16
GB9918178D0 (en) 1999-10-06
PT1287004E (pt) 2005-11-30
HK1050193A1 (en) 2003-06-13
HUP0300648A2 (hu) 2003-07-28
NZ521807A (en) 2004-06-25
HU228789B1 (en) 2013-05-28
EP1287004A1 (en) 2003-03-05
AU2001256496C1 (en) 2006-08-03
PL358143A1 (pl) 2004-08-09
SI1289999T1 (en) 2005-06-30
KR20030005308A (ko) 2003-01-17
EP1289999A1 (en) 2003-03-12

Similar Documents

Publication Publication Date Title
CN100475822C (zh) 生产海鞘素化合物的合成方法
DE60111845T2 (de) Ecteinaschidin derivate mit antikrebs wirkung
US8012975B2 (en) Antitumoral analogs of ET-743
DE60112286T2 (de) Synthetisches verfahren zur herstellung von ecteinascidin-derivaten
AU2001256496A1 (en) Synthetic process for the manufacture of an ecteinascidin compound
UA78680C2 (en) Antitumoral analogs of et-743, pharmaceutical composition based thereon and use thereof
NO329561B1 (no) Forbindelser som er analoger av ET-743, farmasoytiske preparater som omfatter en slik forbindelse, og anvendelse av forbindelsene til fremstilling av farmasoytiske preparater for anvendelse ved behandling av tumorer
UA76418C2 (en) Antitumour derivatives of ecteinascidin , pharmaceutical composition on their basis and a method for the treatment of diseases
Noheda Marín et al. Rearrangement of spirolactams